| Literature DB >> 33498967 |
Shara Francesca Rapa1, Francesco Prisco2, Ada Popolo1, Valentina Iovane1, Giuseppina Autore1, Biagio Raffaele Di Iorio3, Fabrizio Dal Piaz4, Orlando Paciello2, Fuyu Nishijima5, Stefania Marzocco1.
Abstract
The intestines are recognized as the main source of chronic inflammation in chronic kidney disease (CKD) and, among other cells, macrophages are involved in modulating this process as well as in the impaired immune response which also occurs in CKD patients. In this study, we evaluated the effect of Indoxyl Sulfate (IS), a protein bound uremic toxin poorly eliminated by hemodialysis, on inflammatory, oxidative stress and pro-apoptotic parameters, at the intestinal level in mice, on intestinal epithelial cells (IEC-6) and on primary murine peritoneal macrophages. C57BL/6J mice were treated with IS (800 mg/kg i.p.) for 3 or 6 h and histopathological analysis showed that IS induced intestinal inflammation and increased cyclooxygenase-2 (COX-2), nitrotyrosine and Bax expression in intestinal tissue. In IEC-6 cells, IS (125-1000 µM) increased tumor necrosis factor-α levels, COX-2 and inducible nitric oxide synthase expression and nitrotyrosine formation. Moreover, IS increased pro-oxidant, pro-inflammatory and pro-apoptotic parameters in peritoneal macrophages from IS-treated mice. Also, the serum concentration of IS and pro-inflammatory levels of cytokines resulted increased in IS-treated mice. Our results indicate that IS significantly contributes to affect intestinal homeostasis, immune response, and to induce a systemic pro-inflammatory state thus highlighting its potential role as therapeutic target in CKD patients.Entities:
Keywords: chronic kidney disease; indoxyl sulfate; intestinal epithelial cells; intestinal inflammation; oxidative stress; primary murine peritoneal macrophages
Mesh:
Substances:
Year: 2021 PMID: 33498967 PMCID: PMC7865799 DOI: 10.3390/ijms22031135
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923